Day: September 4, 2025
OSLO, Norway (4 September 2025) – TGS, a global leader in energy data and intelligence, in collaboration with joint venture partner Viridien, an advanced technology, digital and earth data company, today announced the commencement of the Megabar Extension Phase I survey in the Barreirinhas Basin offshore Northern Brazil. The 5,300 sq km multi-client 3D seismic survey will be acquired by TGS and imaged by Viridien and builds on Viridien’s Megabar survey coverage.
The Barreirinhas Basin features proven petroleum systems and giant discoveries in adjacent Guyana and Suriname basins that demonstrate analogous deepwater play components. Recent licensing activity by IOCs along the equatorial margin, coupled with the success of Brazil’s 5th Cycle Permanent Concession Offer, supports growing momentum for the region.
Megabar Extension Phase I...
Nicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed
Written by Customer Service on . Posted in Public Companies.
Press ReleaseNicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally LicensedCompany expects to fully repay existing financial debts in 2026
NCX 470 NDA submissions in U.S. (H1 2026) and subsequently in China
Milestones payable on U.S. NDA submission and on approval
Glaukos extends NCX 1728 research agreement
Future strategic options under consideration including collaborations or business combinations
Q&A for shareholders available on the Nicox website: Q&ASeptember 4, 2025 – release at 7:30 am CET Sophia Antipolis, France
Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, today announced that it expects to be able to fully repay all existing financial debts in 2026 and provided an update on its portfolio and financial situation. This follows...
Sampo plc’s share buybacks 3 September 2025
Written by Customer Service on . Posted in Public Companies.
Sampo plc, stock exchange release, 4 September 2025 at 8:30 am EEST
Sampo plc’s share buybacks 3 September 2025                                                   
On 3 September 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:                Sampo plc’s share buybacks
Aggregated daily volume (in number of shares)
Daily weighted average price of the purchased   shares*
Market (MIC   Code) 
9,176
9.55
AQEU   
111,968
9.54
CEUX 
28,305
9.55
TQEX 
188,296
9.55
XHELTOTAL
337,745
9.55
 * rounded to two decimals                     
On 6 August 2025, Sampo announced a share buyback programme of up to a maximum of EUR 200 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation...
Viridien and TGS Announce Megabar Extension Phase I Multi-client Project Offshore Brazil
Written by Customer Service on . Posted in Public Companies.
Paris, France – September 4, 2025
Viridien, an advanced technology, digital and Earth data company, in collaboration with joint venture partner TGS, a global leader in energy data and intelligence, today announced the commencement of the Megabar Extension Phase I survey in the Barreirinhas Basin offshore Northern Brazil. The 5,300 sq km multi-client 3D seismic survey will be acquired by TGS and imaged by Viridien and builds on Viridien’s existing Megabar survey coverage.
The Barreirinhas Basin features proven petroleum systems and giant discoveries in adjacent Guyana and Suriname basins that demonstrate analogous deepwater plays. Recent licensing activity by IOCs along the equatorial margin, coupled with the success of Brazil’s 5th Cycle Permanent Concession Offer, supports growing momentum for the region.
Megabar Extension Phase I will...
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
Written by Customer Service on . Posted in Public Companies.
MINNEAPOLIS and BRISBANE, Australia, Sept.  04, 2025  (GLOBE NEWSWIRE) — Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced that its Special Meeting of Stockholders (the “Special Meeting”), which was originally scheduled to be held on Thursday, September 4, 2025, at 5:00 p.m. Central time (being 8:00 a.m. AEST on Friday, September 5, 2025), has been postponed. The Special Meeting is now scheduled to be held virtually, via live webcast at www.virtualshareholdermeeting.com/AVR2025SM, on Thursday, September 11, 2025, at 5:00 p.m. Central time (being 8:00 a.m. AEST on Friday, September 12, 2025). The record date for the Special Meeting,...
Announcement regarding the progress of the second transaction stage with strategic investor
Written by Customer Service on . Posted in Public Companies.
The company previously informed that in March it attracted a strategic investor – Turkish tourism sector businessman and investor Neset Kockar, who manages international aviation, real estate, tourism and other businesses. In April, the first stage of the transaction was successfully completed, during which N. Kockar acquired 23.2% of the company’s shares from three individual shareholders.
The transaction parties planned to complete the second stage of the transaction by autumn, after which N. Kockar would control 33.19% of Novaturas shares. However, the company received information that the second stage of the transaction is being terminated according to the terms of the concluded agreements, and the transaction parties will continue negotiations regarding new agreement terms.
The exact date by which a new agreement may be reached...
Ackermans & van Haaren supports MRM Health’s Series B financing round of 55 million euros
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Dear shareholder,
Dear Madam, Dear Sir,Ackermans & van Haaren (AvH) supports the Series B financing round totaling 55 million euros of MRM Health, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology.
For AvH, this series B financing round involves an additional investment of 3 million euros and brings its total investment in MRM Health to 10.8 million euros and its fully diluted participation to 14.1%.
Please find the full press release in annex.Best regards
Ackermans & van HaarenAttachmentAckermans & van Haaren supports MRM Health’s Series B financing round (20250904)
Spring Valley Acquisition Corp. III Announces Pricing of $200 Million Initial Public Offering
Written by Customer Service on . Posted in Public Companies.
DALLAS, Sept.  04, 2025  (GLOBE NEWSWIRE) — Spring Valley Acquisition Corp. III (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit on September 3, 2025. The units are expected to be listed for trading on the Nasdaq Global Market under the ticker symbol “SVACU” beginning September 4, 2025. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant of the Company. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the...
Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Sept.  03, 2025  (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it has entered into convertible note subscription agreements with SurgCenter principals and existing Mesoblast shareholders, Gregory George and William Gueck (“Investors”) to issue, at its sole discretion, up to US$50.0 million (A$76.8 million)1 of unsecured convertible notes. The funding is available at Mesoblast’s option, following shareholder approval, to repay or reduce the amount owing to its secured lenders under the existing loan agreements and for general working capital purposes.
Mesoblast Chief Executive Silviu Itescu said: “We appreciate the ongoing support from our major shareholders in ensuring that the Company can optimize its capital structure...
Acceleware Ltd. Announces Closing of Second Tranche of Non-Brokered Private Placement
Written by Customer Service on . Posted in Public Companies.
CALGARY, Alberta, Sept.  03, 2025  (GLOBE NEWSWIRE) — Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (“RF”) power-to-heat technologies targeting process heat for critical minerals, amine regeneration (for carbon capture and other applications), and enhanced oil production, announces that the Company closed the second tranche of the non-brokered private placement of units (the “Units”) further to press releases dated June 30, 2025, July 31, 2025, August 12, 2025 and August 29, 2025 (the “Private Placement”) and distributed a total of 2,090,000 Units under the second tranche of the Private Placement, at a price of $0.10 per Unit, for total gross proceeds of $209,000. In aggregate, the Company has received total gross proceeds of $1,000,334.20 under both the first and...
